's Avatar

@grahamabra.bsky.social

Nephrologist @StanfordNeph, Chair @HDAE_Official, Director Social Media @HemodialysisInt, Defender of the 4 nephrons.

811 Followers  |  728 Following  |  1,725 Posts  |  Joined: 13.11.2024  |  2.2561

Latest posts by grahamabra.bsky.social on Bluesky

Preview
The 2025 NephJC Night, in Houston โ€” NephJC SAVE THE DATE! On FRIDAY night, NOVEMBER 7th, NephJC will be hosting another of its legendary NephJC Nights during ASN Kidney Week

The 2025 #NephJC at #KidneyWk details

www.nephjc.com/news/2025/10...

Thanks to @jadav.bsky.social!

09.10.2025 15:20 โ€” ๐Ÿ‘ 8    ๐Ÿ” 4    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 1
Post image Post image Post image Post image

A startling biopsy. Severe acute TMA in a pt with suspected scleroderma renal crisis. Massive vascular thrombosis, mucoid intimal edema, and early onion skin change associated with severe cortical necrosis. #renalpath #nephsky #pathsky

09.10.2025 03:08 โ€” ๐Ÿ‘ 17    ๐Ÿ” 7    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0

Nailed it.

06.10.2025 20:19 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

The list is short and contains none :)

06.10.2025 20:19 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
Climb Bio Announces CLYM116 Preclinical Data Highlighting Potential for Best-In-Class Therapeutic for IgAN | Climb Bio New preclinical data demonstrate deeper IgA reduction and a longer half-life compared to first-generation anti-APRIL monoclonal antibody CLYM116 Phase 1 trial initiation expected in Q4 2025, with init...

Fascinating that CLYM116 is compared to sibe in a preclinical study. Hope we see more head-to-head comparisons with other leading or emerging agents!

02.10.2025 22:57 โ€” ๐Ÿ‘ 5    ๐Ÿ” 3    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0

These issues are really important

Lots of KOLs pushing multi target therapy in IgA Nephropathy with basically no data in trails to date

Itโ€™s mechanistically appealing but who knows what the right answer is unless we do the studies

06.10.2025 19:44 โ€” ๐Ÿ‘ 2    ๐Ÿ” 1    ๐Ÿ’ฌ 2    ๐Ÿ“Œ 0
Preview
Safety and Efficacy of Long-Term Voclosporin Treatment for Lupus Nephritis in the Phase 3 AURORA 2 Clinical Trial - PubMed Data demonstrate the safety and efficacy of long-term voclosporin treatment over three years of follow-up in patients with LN.

And there is the longer term followup study AURORA 2 that did not show signs of nephrotoxicity (concern of course with CNI)

pubmed.ncbi.nlm.nih.gov/37466424/

01.10.2025 19:56 โ€” ๐Ÿ‘ 2    ๐Ÿ” 1    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Post image Post image

Very strange post singling out Voclosporin and lupus nephritis from the FDA CDER chap

www.linkedin.com/posts/george... since deleted already

h/t @ericweinhandl.bsky.social and @grahamabra.bsky.social

29.09.2025 19:56 โ€” ๐Ÿ‘ 7    ๐Ÿ” 3    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 1

Agreed.

Iโ€™m all for proteinuria reduction to bring in more smart people to kidney disease work but we need to make sure we avoid the never ending phosphate binder style blackhole of believing and writing surrogate outcome altering meds into guidelines

Show me the ๐Ÿ“ˆ GFR!

27.09.2025 22:29 โ€” ๐Ÿ‘ 3    ๐Ÿ” 1    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0

And itโ€™s live

Iptacopan in C3GN makes it to @thelancet.com

www.thelancet.com/journals/lan...

#NephSky

26.09.2025 09:37 โ€” ๐Ÿ‘ 23    ๐Ÿ” 11    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
Video thumbnail

A 52-year-old woman with hypertension presented to the hospital with a 1-month history of fatigue, as well as 6 days of vomiting and 1 day of confusion. Over the past 20 years, she had not received regular treatment for hypertension. 1/2

#MedSky

26.09.2025 18:54 โ€” ๐Ÿ‘ 9    ๐Ÿ” 2    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 1
Post image

Small group Peritoneal Dialysis case discussion leaders at the Home Dialysis Academy of Excellence!

Drs Ananthakrishnan and Young from UC Davis Division of Nephrology Dr @grahamabra.bsky.social from Stanford Division of Nephrology and Dr Harini Sarathy from UCSF Division of Nephrology

24.09.2025 14:49 โ€” ๐Ÿ‘ 3    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
NephJC 2025 Fall Pledge Drive โ€” NephJC Help keep NephJC a vital, original, and unbiased source of medical education.

It's that time of year again ๐Ÿ‚๐Ÿ‚๐Ÿ‚
The #NephJC Fall pledge drive.
Plese give if you are able to support our decades long mission of #FOAMed for all. #NephSky #MedSky
www.nephjc.com/news/2025/9/22/nephjc-fall-pledge-drive

22.09.2025 00:47 โ€” ๐Ÿ‘ 14    ๐Ÿ” 12    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 1

I teach it. I have not seen this studied in a systematic way, but Edelman equation is not just a good idea, itโ€™s the law.

20.09.2025 02:40 โ€” ๐Ÿ‘ 4    ๐Ÿ” 1    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

Has anyone studied the use of K supplementation to increase daily solute load and subsequently free water excretion in SIADH?

#AskRenal

19.09.2025 19:43 โ€” ๐Ÿ‘ 4    ๐Ÿ” 3    ๐Ÿ’ฌ 4    ๐Ÿ“Œ 0

Certainly warrants more investigation, understudied area, we need good prospective RCTs targeting CGM metrics and/or HbA1c in ESKD showing improvement in important clinical outcomes (DM complications, hospitalizations ect) to know

19.09.2025 16:05 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0

๐Ÿคฆโ€โ™‚๏ธ

19.09.2025 15:59 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Preview
A new era of lupus nephritis therapy is here Lupus nephritis occurs in approximately half of patients diagnosed with systemic lupus erythematosus. One in 10 patients with lupus nephritis will progress to end-stage kidney disease, and risk is hig...

Itโ€™s an exciting time to be taking care of patients with Lupus Nephritis!

www.healio.com/news/nephrol...

18.09.2025 20:28 โ€” ๐Ÿ‘ 6    ๐Ÿ” 4    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

Calling @hswapnil.medsky.social

๐Ÿšจ vitamin D alert ๐Ÿšจ

18.09.2025 20:27 โ€” ๐Ÿ‘ 5    ๐Ÿ” 2    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
Preview
Glycemia Assessed by Continuous Glucose Monitoring among... : Journal of the American Society of Nephrology ilure and its treatments disrupt glucose homeostasis in ways that may promote both hyperglycemia and hypoglycemia. Continuous glucose monitoring (CGM) delineates detailed glycemic profiles, but publis...

Hereโ€™s the link to the paper - original post has the poster

journals.lww.com/jasn/fulltex...

14.09.2025 22:30 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

Great question.

Donโ€™t know myself but always been fascinated by the question of why PD and HD mortality outcomes are the same despite being totally different modalities

Do the metabolic complications outweigh the other benefits of PD (eg better kidney function preservation)?

14.09.2025 15:42 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

#AskRenal

14.09.2025 15:11 โ€” ๐Ÿ‘ 1    ๐Ÿ” 0    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

Huge kudos to Northwest Kidney for making this study possible

This is the kind of pragmatic ESKD research we need

Non-profit reinvesting in the mission!

14.09.2025 00:23 โ€” ๐Ÿ‘ 3    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0

One of the limitations of drug dosing studies is that they have historically used CrCl, always a bit of guesswork when using other estimates of kidney function

13.09.2025 21:14 โ€” ๐Ÿ‘ 4    ๐Ÿ” 1    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0

Curious if folks ever use this in setting of rapidly rising creatinine to make med dosing decisions - why or why not?

#AskRenal @askrenal.bsky.social

www.mdcalc.com/calc/10191/k...

08.09.2025 22:16 โ€” ๐Ÿ‘ 7    ๐Ÿ” 4    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
Post image

The metabolic stress of PD is real!

Check out the mean glucose across the day - that cycler really hits those with treated DM!

13.09.2025 19:34 โ€” ๐Ÿ‘ 5    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0

The PD (n=55) findings are fascinating

No DM, mean (SD) blood glucose was 121 (16) mg/dl for participants treated with HD and 141 (25) mg/dl for those treated with PD (P < 0.001)

The mean TIR (70โ€“140 mg/dl) was 77% for HD and 55% for PD, w/ most of remaining time spent above range (>140 mg/dl)!

13.09.2025 19:27 โ€” ๐Ÿ‘ 0    ๐Ÿ” 0    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0
Preview
Glycemia Assessed by Continuous Glucose Monitoring among... : Journal of the American Society of Nephrology ilure and its treatments disrupt glucose homeostasis in ways that may promote both hyperglycemia and hypoglycemia. Continuous glucose monitoring (CGM) delineates detailed glycemic profiles, but publis...

Have hyperglycemia (and other DM badness) been hiding in plain sight in ESKD?

Probably.

Great study using CGMs in ESKD.

Pts with treated DM, mean TIR only 43% while mean HbA1c was 7.0%

journals.lww.com/jasn/abstrac...

13.09.2025 19:16 โ€” ๐Ÿ‘ 12    ๐Ÿ” 7    ๐Ÿ’ฌ 3    ๐Ÿ“Œ 1

If you are seeing patients with #ckm (cardiac, kidney, metabolic) syndrome, you should be aiming for (and justifying if you are not) the #RuleOf10: 10mg of each of Ramipril, Empagliflozin, Finerenone, Rosuvastatin, Ezetimibe, Tirzepatide for your patients (or equivalent doses of similar drugs).

07.09.2025 00:22 โ€” ๐Ÿ‘ 6    ๐Ÿ” 3    ๐Ÿ’ฌ 0    ๐Ÿ“Œ 0
Post image

A famous nephrologist getting ready to go see the most famous guy who plays a nephrologist @glaucomflecken.bsky.social @stanforddeptmed.bsky.social Grand Rounds!

05.09.2025 16:27 โ€” ๐Ÿ‘ 12    ๐Ÿ” 4    ๐Ÿ’ฌ 1    ๐Ÿ“Œ 0

@grahamabra is following 19 prominent accounts